Home › Johnson & Johnson , ViiV Healthcare: 2 injections every month or 2 could keep HIV at bay
 

Keywords :   


Johnson & Johnson , ViiV Healthcare: 2 injections every month or 2 could keep HIV at bay

2015-11-04 09:14:27| Biotech - Topix.net

Preliminary testing of two long-acting injectable drugs indicates it might be possible to keep HIV at bay indefinitely with injections every month or two. Johnson & Johnson and partner ViiV Healthcare, which specializes in HIV drugs, announced results from the first 32 weeks of the planned 96-week study, which combines one drug from each company.

Tags: at month keep bay

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.05Hempel Announces Intent to Divest J.W. Ostendorf and Renaulac
06.05California Attorney General To Speak at PCPC 2024 Legal Conference
06.05BASF Enters Agreement with International Process Plants
06.05Techkon receives FTA Technical Innovation Award
06.05EltaMD Unveils Patent-Pending Innovation with Major League Pickleball Sponsorship on Melanoma ...
06.05Perfect Corp. Unveils Unique Beautiful AI Brand Solutions at Viva Technology 2024
06.05FTA announces 2024 awards winners
06.05XSYS launches Catena ProServX
More »